Muc4/MUC4 functions and regulation in cancer

被引:56
作者
Carraway, Kermit L. [1 ]
Theodoropoulos, George [1 ]
Kozloski, Goldi A. [1 ]
Carraway, Coralie A. Carothers [2 ]
机构
[1] Univ Miami, Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA
[2] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA
关键词
adhesion; apoptosis; ErbB2/ErbB3; regulation; ligand; membrane mucin; metastasis; MUC4; post-translational regulation; proteosomal degradation; transcription; MAMMARY ADENOCARCINOMA CELLS; GROWTH-FACTOR-BETA; INTRAMEMBRANE ERBB2 LIGAND; SURFACE SIALOMUCIN COMPLEX; HUMAN MUCIN MUC4; PANCREATIC TUMOR-CELLS; EPITHELIAL-CELLS; MUC4/SIALOMUCIN COMPLEX; RAT MUC4; MOLECULAR-CLONING;
D O I
10.2217/FON.09.125
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The membrane mucin MUC4 (human) is abundantly expressed in many epithelia, where it is proposed to play a protective role, and is overexpressed in some epithelial tumors. Studies on the rat homologue, Muc4, indicate that it acts through anti-adhesive or signaling mechanisms. In particular, Muc4/MUC4 serve as a ligand/modulator of the receptor tyrosine kinase ErbB2, regulating its phosphorylation and the phosphorylation of its partner ErbB3 with or without the involvement of the ErbB3 ligand neuregulin. Muc4/MUC4 can also modulate cell apoptosis via multiple mechanisms, both ErbB2 dependent and independent. Muc4/MUC4 expression is regulated by multiple mechanisms, ranging from transcriptional to post-translational. The roles of MUC4 in tumors suggest that it may be valuable as a tumor marker or target for therapy.
引用
收藏
页码:1631 / 1640
页数:10
相关论文
共 89 条
[71]  
SHERBLOM AP, 1980, J BIOL CHEM, V255, P783
[72]   MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type [J].
Shibahara, H ;
Tamada, S ;
Higashi, M ;
Goto, M ;
Batra, SK ;
Hollingsworth, MA ;
Imai, K ;
Yonezawa, S .
HEPATOLOGY, 2004, 39 (01) :220-229
[73]   MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms [J].
Singh, A. P. ;
Chauhan, S. C. ;
Andrianifahanana, M. ;
Moniaux, N. ;
Meza, J. L. ;
Copin, M. C. ;
van Seuningen, I. ;
Hollingsworth, M. A. ;
Aubert, J. P. ;
Batra, S. K. .
ONCOGENE, 2007, 26 (01) :30-41
[74]   Emerging roles of MUC4 in cancer: A novel target for diagnosis and therapy [J].
Singh, Ajay P. ;
Chaturvedi, PaHavi ;
Batra, Surinder K. .
CANCER RESEARCH, 2007, 67 (02) :433-436
[75]   Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis [J].
Singh, AP ;
Moniaux, N ;
Chauhan, SC ;
Meza, JL ;
Batra, SK .
CANCER RESEARCH, 2004, 64 (02) :622-630
[76]   SMAD2 and SMAD7 involvement in the post-translational regulation of Muc4 via the transforming growth factor-β and interferon-γ pathways in rat mammary epithelial cells [J].
Soto, P ;
Price-Schiavi, SA ;
Carraway, KL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (22) :20338-20344
[77]  
Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791
[78]   MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma [J].
Tamada, Shugo ;
Shibahara, Hiroaki ;
Higashi, Michiyo ;
Goto, Masamichi ;
Batra, Surinder K. ;
Imai, Kohzoh ;
Yonezawa, Suguru .
CLINICAL CANCER RESEARCH, 2006, 12 (14) :4257-4264
[79]   MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma [J].
Tsutsumida, Hideaki ;
Goto, Masamichi ;
Kitajima, Shinichi ;
Kubota, Ichiro ;
Hirotsu, Yasunobu ;
Wakimoto, Joeji ;
Batra, Surinder K. ;
Imai, Kohzoh ;
Yonezawa, Suguru .
LUNG CANCER, 2007, 55 (02) :195-203
[80]  
VANSEUNINGEN I, 2009, EXPERT OPIN IN PRESS